ICD-10-CM FY2022 code changes
Effective 2021-10-01.
Added to the code set (201)
- A79.82 — Anaplasmosis [A. phagocytophilum]
- C56.3 — Malignant neoplasm of bilateral ovaries
- C79.63 — Secondary malignant neoplasm of bilateral ovaries
- C84.7A — Anaplastic large cell lymphoma, ALK-negative, breast
- D55.21 — Anemia due to pyruvate kinase deficiency
- D55.29 — Anemia due to other disorders of glycolytic enzymes
- D75.83 — Thrombocytosis
- D75.838 — Other thrombocytosis
- D75.839 — Thrombocytosis, unspecified
- D89.44 — Hereditary alpha tryptasemia
- E75.244 — Niemann-Pick disease type A/B
- F32.A — Depression, unspecified
- F78.A — Other genetic related intellectual disabilities
- F78.A1 — SYNGAP1-related intellectual disability
- F78.A9 — Other genetic related intellectual disability
- G04.82 — Acute flaccid myelitis
- G44.86 — Cervicogenic headache
- G92.0 — Immune effector cell-associated neurotoxicity syndrome
- G92.00 — Immune effector cell-associated neurotoxicity syndrome, grade unspecified
- G92.01 — Immune effector cell-associated neurotoxicity syndrome, grade 1
- G92.02 — Immune effector cell-associated neurotoxicity syndrome, grade 2
- G92.03 — Immune effector cell-associated neurotoxicity syndrome, grade 3
- G92.04 — Immune effector cell-associated neurotoxicity syndrome, grade 4
- G92.05 — Immune effector cell-associated neurotoxicity syndrome, grade 5
- G92.8 — Other toxic encephalopathy
- G92.9 — Unspecified toxic encephalopathy
- I5A — Non-ischemic myocardial injury (non-traumatic)
- J12.82 — Pneumonia due to coronavirus disease 2019
- K22.81 — Esophageal polyp
- K22.82 — Esophagogastric junction polyp
- K22.89 — Other specified disease of esophagus
- K31.A — Gastric intestinal metaplasia
- K31.A0 — Gastric intestinal metaplasia, unspecified
- K31.A1 — Gastric intestinal metaplasia without dysplasia
- K31.A11 — Gastric intestinal metaplasia without dysplasia, involving the antrum
- K31.A12 — Gastric intestinal metaplasia without dysplasia, involving the body (corpus)
- K31.A13 — Gastric intestinal metaplasia without dysplasia, involving the fundus
- K31.A14 — Gastric intestinal metaplasia without dysplasia, involving the cardia
- K31.A15 — Gastric intestinal metaplasia without dysplasia, involving multiple sites
- K31.A19 — Gastric intestinal metaplasia without dysplasia, unspecified site
- K31.A2 — Gastric intestinal metaplasia with dysplasia
- K31.A21 — Gastric intestinal metaplasia with low grade dysplasia
- K31.A22 — Gastric intestinal metaplasia with high grade dysplasia
- K31.A29 — Gastric intestinal metaplasia with dysplasia, unspecified
- L24.A — Irritant contact dermatitis due to friction or contact with body fluids
- L24.A0 — Irritant contact dermatitis due to friction or contact with body fluids, unspecified
- L24.A1 — Irritant contact dermatitis due to saliva
- L24.A2 — Irritant contact dermatitis due to fecal, urinary or dual incontinence
- L24.A9 — Irritant contact dermatitis due friction or contact with other specified body fluids
- L24.B — Irritant contact dermatitis related to stoma or fistula
- L24.B0 — Irritant contact dermatitis related to unspecified stoma or fistula
- L24.B1 — Irritant contact dermatitis related to digestive stoma or fistula
- L24.B2 — Irritant contact dermatitis related to respiratory stoma or fistula
- L24.B3 — Irritant contact dermatitis related to fecal or urinary stoma or fistula
- M31.10 — Thrombotic microangiopathy, unspecified
- M31.11 — Hematopoietic stem cell transplantation-associated thrombotic microangiopathy [HSCT-TMA]
- M31.19 — Other thrombotic microangiopathy
- M35.05 — Sjogren syndrome with inflammatory arthritis
- M35.06 — Sjogren syndrome with peripheral nervous system involvement
- M35.07 — Sjogren syndrome with central nervous system involvement
- M35.08 — Sjogren syndrome with gastrointestinal involvement
- M35.0A — Sjogren syndrome with glomerular disease
- M35.0B — Sjogren syndrome with vasculitis
- M35.0C — Sjogren syndrome with dental involvement
- M35.81 — Multisystem inflammatory syndrome
- M35.89 — Other specified systemic involvement of connective tissue
- M45.A — Non-radiographic axial spondyloarthritis
- M45.A0 — Non-radiographic axial spondyloarthritis of unspecified sites in spine
- M45.A1 — Non-radiographic axial spondyloarthritis of occipito-atlanto-axial region
- M45.A2 — Non-radiographic axial spondyloarthritis of cervical region
- M45.A3 — Non-radiographic axial spondyloarthritis of cervicothoracic region
- M45.A4 — Non-radiographic axial spondyloarthritis of thoracic region
- M45.A5 — Non-radiographic axial spondyloarthritis of thoracolumbar region
- M45.A6 — Non-radiographic axial spondyloarthritis of lumbar region
- M45.A7 — Non-radiographic axial spondyloarthritis of lumbosacral region
- M45.A8 — Non-radiographic axial spondyloarthritis of sacral and sacrococcygeal region
- M45.AB — Non-radiographic axial spondyloarthritis of multiple sites in spine
- M54.50 — Low back pain, unspecified
- M54.51 — Vertebrogenic low back pain
- M54.59 — Other low back pain
- P00.82 — Newborn affected by (positive) maternal group B streptococcus (GBS) colonization
- P09.1 — Abnormal findings on neonatal screening for inborn errors of metabolism
- P09.2 — Abnormal findings on neonatal screening for congenital endocrine disease
- P09.3 — Abnormal findings on neonatal screening for congenital hematologic disorders
- P09.4 — Abnormal findings on neonatal screening for cystic fibrosis
- P09.5 — Abnormal findings on neonatal screening for critical congenital heart disease
- P09.6 — Abnormal findings on neonatal screening for neonatal hearing loss
- P09.8 — Other abnormal findings on neonatal screening
- P09.9 — Abnormal findings on neonatal screening, unspecified
- R05.1 — Acute cough
- R05.2 — Subacute cough
- R05.3 — Chronic cough
- R05.4 — Cough syncope
- R05.8 — Other specified cough
- R05.9 — Cough, unspecified
- R35.81 — Nocturnal polyuria
- R35.89 — Other polyuria
- R45.88 — Nonsuicidal self-harm
- R63.30 — Feeding difficulties, unspecified
- R63.31 — Pediatric feeding disorder, acute
- R63.32 — Pediatric feeding disorder, chronic
- R63.39 — Other feeding difficulties
- R79.83 — Abnormal findings of blood amino-acid level
- S06.A — Traumatic brain compression and herniation
- S06.A0 — Traumatic brain compression without herniation
- S06.A0XA — Traumatic brain compression without herniation, initial encounter
- S06.A0XD — Traumatic brain compression without herniation, subsequent encounter
- S06.A0XS — Traumatic brain compression without herniation, sequela
- S06.A1 — Traumatic brain compression with herniation
- S06.A1XA — Traumatic brain compression with herniation, initial encounter
- S06.A1XD — Traumatic brain compression with herniation, subsequent encounter
- S06.A1XS — Traumatic brain compression with herniation, sequela
- T40.71 — Poisoning by, adverse effect of and underdosing of cannabis (derivatives)
- T40.711 — Poisoning by cannabis, accidental (unintentional)
- T40.711A — Poisoning by cannabis, accidental (unintentional), initial encounter
- T40.711D — Poisoning by cannabis, accidental (unintentional), subsequent encounter
- T40.711S — Poisoning by cannabis, accidental (unintentional), sequela
- T40.712 — Poisoning by cannabis, intentional self-harm
- T40.712A — Poisoning by cannabis, intentional self-harm, initial encounter
- T40.712D — Poisoning by cannabis, intentional self-harm, subsequent encounter
- T40.712S — Poisoning by cannabis, intentional self-harm, sequela
- T40.713 — Poisoning by cannabis, assault
- T40.713A — Poisoning by cannabis, assault, initial encounter
- T40.713D — Poisoning by cannabis, assault, subsequent encounter
- T40.713S — Poisoning by cannabis, assault, sequela
- T40.714 — Poisoning by cannabis, undetermined
- T40.714A — Poisoning by cannabis, undetermined, initial encounter
- T40.714D — Poisoning by cannabis, undetermined, subsequent encounter
- T40.714S — Poisoning by cannabis, undetermined, sequela
- T40.715 — Adverse effect of cannabis
- T40.715A — Adverse effect of cannabis, initial encounter
- T40.715D — Adverse effect of cannabis, subsequent encounter
- T40.715S — Adverse effect of cannabis, sequela
- T40.716 — Underdosing of cannabis
- T40.716A — Underdosing of cannabis, initial encounter
- T40.716D — Underdosing of cannabis, subsequent encounter
- T40.716S — Underdosing of cannabis, sequela
- T40.72 — Poisoning by, adverse effect of and underdosing of synthetic cannabinoids
- T40.721 — Poisoning by synthetic cannabinoids, accidental (unintentional)
- T40.721A — Poisoning by synthetic cannabinoids, accidental (unintentional), initial encounter
- T40.721D — Poisoning by synthetic cannabinoids, accidental (unintentional), subsequent encounter
- T40.721S — Poisoning by synthetic cannabinoids, accidental (unintentional), sequela
- T40.722 — Poisoning by synthetic cannabinoids, intentional self-harm
- T40.722A — Poisoning by synthetic cannabinoids, intentional self-harm, initial encounter
- T40.722D — Poisoning by synthetic cannabinoids, intentional self-harm, subsequent encounter
- T40.722S — Poisoning by synthetic cannabinoids, intentional self-harm, sequela
- T40.723 — Poisoning by synthetic cannabinoids, assault
- T40.723A — Poisoning by synthetic cannabinoids, assault, initial encounter
- T40.723D — Poisoning by synthetic cannabinoids, assault, subsequent encounter
- T40.723S — Poisoning by synthetic cannabinoids, assault, sequela
- T40.724 — Poisoning by synthetic cannabinoids, undetermined
- T40.724A — Poisoning by synthetic cannabinoids, undetermined, initial encounter
- T40.724D — Poisoning by synthetic cannabinoids, undetermined, subsequent encounter
- T40.724S — Poisoning by synthetic cannabinoids, undetermined, sequela
- T40.725 — Adverse effect of synthetic cannabinoids
- T40.725A — Adverse effect of synthetic cannabinoids, initial encounter
- T40.725D — Adverse effect of synthetic cannabinoids, subsequent encounter
- T40.725S — Adverse effect of synthetic cannabinoids, sequela
- T40.726 — Underdosing of synthetic cannabinoids
- T40.726A — Underdosing of synthetic cannabinoids, initial encounter
- T40.726D — Underdosing of synthetic cannabinoids, subsequent encounter
- T40.726S — Underdosing of synthetic cannabinoids, sequela
- T80.82 — Complication of immune effector cellular therapy
- T80.82XA — Complication of immune effector cellular therapy, initial encounter
- T80.82XD — Complication of immune effector cellular therapy, subsequent encounter
- T80.82XS — Complication of immune effector cellular therapy, sequela
- U09 — Post COVID-19 condition
- U09.9 — Post COVID-19 condition, unspecified
- Y35.899 — Legal intervention involving other specified means, unspecified person injured
- Y35.899A — Legal intervention involving other specified means, unspecified person injured, initial encounter
- Y35.899D — Legal intervention involving other specified means, unspecified person injured, subsequent encounter
- Y35.899S — Legal intervention involving other specified means, unspecified person injured, sequela
- Z11.52 — Encounter for screening for COVID-19
- Z20.822 — Contact with and (suspected) exposure to COVID-19
- Z28.31 — Underimmunization for COVID-19 status
- Z28.310 — Unvaccinated for COVID-19
- Z28.311 — Partially vaccinated for COVID-19
- Z28.39 — Other underimmunization status
- Z55.5 — Less than a high school diploma
- Z58 — Problems related to physical environment
- Z58.6 — Inadequate drinking-water supply
- Z59.00 — Homelessness unspecified
- Z59.01 — Sheltered homelessness
- Z59.02 — Unsheltered homelessness
- Z59.41 — Food insecurity
- Z59.48 — Other specified lack of adequate food
- Z59.81 — Housing instability, housed
- Z59.811 — Housing instability, housed, with risk of homelessness
- Z59.812 — Housing instability, housed, homelessness in past 12 months
- Z59.819 — Housing instability, housed unspecified
- Z59.89 — Other problems related to housing and economic circumstances
- Z71.85 — Encounter for immunization safety counseling
- Z86.16 — Personal history of COVID-19
- Z91.014 — Allergy to mammalian meats
- Z91.51 — Personal history of suicidal behavior
- Z91.52 — Personal history of nonsuicidal self-harm
- Z92.85 — Personal history of cellular therapy
- Z92.850 — Personal history of Chimeric Antigen Receptor T-cell therapy
- Z92.858 — Personal history of other cellular therapy
- Z92.859 — Personal history of cellular therapy, unspecified
- Z92.86 — Personal history of gene therapy
Removed from the code set (25)
- T40.7X — Poisoning by, adverse effect of and underdosing of cannabis (derivatives)
- T40.7X1 — Poisoning by cannabis (derivatives), accidental (unintentional)
- T40.7X1A — Poisoning by cannabis (derivatives), accidental (unintentional), initial encounter
- T40.7X1D — Poisoning by cannabis (derivatives), accidental (unintentional), subsequent encounter
- T40.7X1S — Poisoning by cannabis (derivatives), accidental (unintentional), sequela
- T40.7X2 — Poisoning by cannabis (derivatives), intentional self-harm
- T40.7X2A — Poisoning by cannabis (derivatives), intentional self-harm, initial encounter
- T40.7X2D — Poisoning by cannabis (derivatives), intentional self-harm, subsequent encounter
- T40.7X2S — Poisoning by cannabis (derivatives), intentional self-harm, sequela
- T40.7X3 — Poisoning by cannabis (derivatives), assault
- T40.7X3A — Poisoning by cannabis (derivatives), assault, initial encounter
- T40.7X3D — Poisoning by cannabis (derivatives), assault, subsequent encounter
- T40.7X3S — Poisoning by cannabis (derivatives), assault, sequela
- T40.7X4 — Poisoning by cannabis (derivatives), undetermined
- T40.7X4A — Poisoning by cannabis (derivatives), undetermined, initial encounter
- T40.7X4D — Poisoning by cannabis (derivatives), undetermined, subsequent encounter
- T40.7X4S — Poisoning by cannabis (derivatives), undetermined, sequela
- T40.7X5 — Adverse effect of cannabis (derivatives)
- T40.7X5A — Adverse effect of cannabis (derivatives), initial encounter
- T40.7X5D — Adverse effect of cannabis (derivatives), subsequent encounter
- T40.7X5S — Adverse effect of cannabis (derivatives), sequela
- T40.7X6 — Underdosing of cannabis (derivatives)
- T40.7X6A — Underdosing of cannabis (derivatives), initial encounter
- T40.7X6D — Underdosing of cannabis (derivatives), subsequent encounter
- T40.7X6S — Underdosing of cannabis (derivatives), sequela
Description revised (30)
- F32 — Major depressive disorder, single episode → Depressive episode
- G71.20 — Congenital myopathy, unspecifed → Congenital myopathy, unspecified
- M35.0 — Sicca syndrome [Sjogren] → Sjogren syndrome
- M35.00 — Sicca syndrome, unspecified → Sjogren syndrome, unspecified
- M35.01 — Sicca syndrome with keratoconjunctivitis → Sjogren syndrome with keratoconjunctivitis
- M35.02 — Sicca syndrome with lung involvement → Sjogren syndrome with lung involvement
- M35.03 — Sicca syndrome with myopathy → Sjogren syndrome with myopathy
- M35.04 — Sicca syndrome with tubulo-interstitial nephropathy → Sjogren syndrome with tubulo-interstitial nephropathy
- M35.09 — Sicca syndrome with other organ involvement → Sjogren syndrome with other organ involvement
- T63.61 — Toxic effect of contact with Portugese Man-o-war → Toxic effect of contact with Portuguese Man-o-war
- T63.611 — Toxic effect of contact with Portugese Man-o-war, accidental (unintentional) → Toxic effect of contact with Portuguese Man-o-war, accidental (unintentional)
- T63.611A — Toxic effect of contact with Portugese Man-o-war, accidental (unintentional), initial encounter → Toxic effect of contact with Portuguese Man-o-war, accidental (unintentional), initial encounter
- T63.611D — Toxic effect of contact with Portugese Man-o-war, accidental (unintentional), subsequent encounter → Toxic effect of contact with Portuguese Man-o-war, accidental (unintentional), subsequent encounter
- T63.611S — Toxic effect of contact with Portugese Man-o-war, accidental (unintentional), sequela → Toxic effect of contact with Portuguese Man-o-war, accidental (unintentional), sequela
- T63.612 — Toxic effect of contact with Portugese Man-o-war, intentional self-harm → Toxic effect of contact with Portuguese Man-o-war, intentional self-harm
- T63.612A — Toxic effect of contact with Portugese Man-o-war, intentional self-harm, initial encounter → Toxic effect of contact with Portuguese Man-o-war, intentional self-harm, initial encounter
- T63.612D — Toxic effect of contact with Portugese Man-o-war, intentional self-harm, subsequent encounter → Toxic effect of contact with Portuguese Man-o-war, intentional self-harm, subsequent encounter
- T63.612S — Toxic effect of contact with Portugese Man-o-war, intentional self-harm, sequela → Toxic effect of contact with Portuguese Man-o-war, intentional self-harm, sequela
- T63.613 — Toxic effect of contact with Portugese Man-o-war, assault → Toxic effect of contact with Portuguese Man-o-war, assault
- T63.613A — Toxic effect of contact with Portugese Man-o-war, assault, initial encounter → Toxic effect of contact with Portuguese Man-o-war, assault, initial encounter
- T63.613D — Toxic effect of contact with Portugese Man-o-war, assault, subsequent encounter → Toxic effect of contact with Portuguese Man-o-war, assault, subsequent encounter
- T63.613S — Toxic effect of contact with Portugese Man-o-war, assault, sequela → Toxic effect of contact with Portuguese Man-o-war, assault, sequela
- T63.614 — Toxic effect of contact with Portugese Man-o-war, undetermined → Toxic effect of contact with Portuguese Man-o-war, undetermined
- T63.614A — Toxic effect of contact with Portugese Man-o-war, undetermined, initial encounter → Toxic effect of contact with Portuguese Man-o-war, undetermined, initial encounter
- T63.614D — Toxic effect of contact with Portugese Man-o-war, undetermined, subsequent encounter → Toxic effect of contact with Portuguese Man-o-war, undetermined, subsequent encounter
- T63.614S — Toxic effect of contact with Portugese Man-o-war, undetermined, sequela → Toxic effect of contact with Portuguese Man-o-war, undetermined, sequela
- Z59.4 — Lack of adequate food and safe drinking water → Lack of adequate food
- Z68.30 — Body mass index [BMI]30.0-30.9, adult → Body mass index [BMI] 30.0-30.9, adult
- Z68.41 — Body mass index [BMI]40.0-44.9, adult → Body mass index [BMI] 40.0-44.9, adult
- Z92.25 — Personal history of immunosupression therapy → Personal history of immunosuppression therapy
Short description revised (30)
- F32 — Major depressive disorder, single episode → Depressive episode
- G71.20 — Congenital myopathy, unspecifed → Congenital myopathy, unspecified
- M35.0 — Sicca syndrome [Sjogren] → Sjogren syndrome
- M35.00 — Sicca syndrome, unspecified → Sjogren syndrome, unspecified
- M35.01 — Sicca syndrome with keratoconjunctivitis → Sjogren syndrome with keratoconjunctivitis
- M35.02 — Sicca syndrome with lung involvement → Sjogren syndrome with lung involvement
- M35.03 — Sicca syndrome with myopathy → Sjogren syndrome with myopathy
- M35.04 — Sicca syndrome with tubulo-interstitial nephropathy → Sjogren syndrome with tubulo-interstitial nephropathy
- M35.09 — Sicca syndrome with other organ involvement → Sjogren syndrome with other organ involvement
- T63.61 — Toxic effect of contact with Portugese Man-o-war → Toxic effect of contact with Portuguese Man-o-war
- T63.611 — Toxic effect of contact w Portugese Man-o-war, accidental → Toxic effect of contact with Portuguese Man-o-war, acc
- T63.611A — Toxic effect of contact w Portugese Man-o-war, acc, init → Toxic effect of cntct with Portuguese Man-o-war, acc, init
- T63.611D — Toxic effect of contact w Portugese Man-o-war, acc, subs → Toxic effect of cntct with Portuguese Man-o-war, acc, subs
- T63.611S — Toxic effect of contact w Portugese Man-o-war, acc, sequela → Toxic effect of cntct with Portuguese Man-o-war, acc, sqla
- T63.612 — Toxic effect of contact w Portugese Man-o-war, self-harm → Toxic effect of contact with Portuguese Man-o-war, self-harm
- T63.612A — Toxic effect of contact w Portugese Man-o-war, slf-hrm, init → Toxic eff of cntct with Portuguese Man-o-war, slf-hrm, init
- T63.612D — Toxic effect of contact w Portugese Man-o-war, slf-hrm, subs → Toxic eff of cntct with Portuguese Man-o-war, slf-hrm, subs
- T63.612S — Toxic effect of cntct w Portugese Man-o-war, slf-hrm, sqla → Toxic eff of cntct with Portuguese Man-o-war, slf-hrm, sqla
- T63.613 — Toxic effect of contact with Portugese Man-o-war, assault → Toxic effect of contact with Portuguese Man-o-war, assault
- T63.613A — Toxic effect of contact w Portugese Man-o-war, assault, init → Toxic effect of cntct with Portuguese Man-o-war, asslt, init
- T63.613D — Toxic effect of contact w Portugese Man-o-war, assault, subs → Toxic effect of cntct with Portuguese Man-o-war, asslt, subs
- T63.613S — Toxic effect of cntct w Portugese Man-o-war, asslt, sequela → Toxic effect of cntct with Portuguese Man-o-war, asslt, sqla
- T63.614 — Toxic effect of contact w Portugese Man-o-war, undetermined → Toxic effect of contact with Portuguese Man-o-war, undet
- T63.614A — Toxic effect of contact w Portugese Man-o-war, undet, init → Toxic effect of cntct with Portuguese Man-o-war, undet, init
- T63.614D — Toxic effect of contact w Portugese Man-o-war, undet, subs → Toxic effect of cntct with Portuguese Man-o-war, undet, subs
- T63.614S — Toxic effect of cntct w Portugese Man-o-war, undet, sequela → Toxic effect of cntct with Portuguese Man-o-war, undet, sqla
- Z59.4 — Lack of adequate food and safe drinking water → Lack of adequate food
- Z68.30 — Body mass index [BMI]30.0-30.9, adult → Body mass index [BMI] 30.0-30.9, adult
- Z68.41 — Body mass index [BMI]40.0-44.9, adult → Body mass index [BMI] 40.0-44.9, adult
- Z92.25 — Personal history of immunosupression therapy → Personal history of immunosuppression therapy